首页> 外文期刊>FEMS Microbiology Letters >Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties
【24h】

Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties

机译:大肠杆菌菌株Nissle 1917-从工作台到床头和返回:益生菌特殊大肠杆菌菌株的历史

获取原文
获取原文并翻译 | 示例
       

摘要

Among the gram-negative microorganisms with probiotic properties, Escherichia coli strain Nissle 1917 (briefly EcN) is probably the most intensively investigated bacterial strain today. Since nearly 100 years, the EcN strain is used as the active pharmaceutical ingredient in a licensed medicinal product that is distributed in Germany and several other countries. Over the last few decades, novel probiotic activities have been detected, which taken together are specific of this versatile E. coli strain. This review gives a short overview on the discovery and history of the EcN strain.
机译:在具有益生菌性质的革兰氏阴性微生物中,大肠杆菌菌株1917(简要的ECN)可能是今天最强烈的研究细菌菌株。 由于近100年,ECN菌株用作在德国和其他几个国家分布的持牌药品中的活性药物成分。 在过去的几十年中,已经检测到新的益生菌活性,其组合在一起是这种通用的大肠杆菌菌株的特异性。 此审查简要概述了ECN应变的发现和历史。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号